• BX Home
  • Pharmaceutical Industry: [Page 10]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

PHARMACEUTICAL INDUSTRY

save topic

The pharmaceutical industry operates under unique circumstances: Estimates of the cost to bring a single new drug to market range from $800 million to $1.2 billion, and on average, a patent’s life remaining upon FDA launch approval is only eight years. Thus, achieving the highest level of performance is critical to pharmaceutical companies. This topic is dedicated to marketing, market research, business operations, and management issues specific to the pharmaceutical industry.

Pharmaceutical Industry is part of Business Exchange, suggested by Ken Rhines. This topic contains 2,085 news and 770 blog items. Read updated news, blogs, and resources about Pharmaceutical Industry. Find user-submitted articles and reactions on Pharmaceutical Industry from like-minded professionals.

suggest topic

Most Active

The most active stories in this topic based on user activity.

Add

Will medical education help to fill the credibility gap in pharma?more

To learn more about the need for credible branded medical education, Med Ad News spoke with Dave Recht, CEO of North...

srcomblog.wordpress.com. Added to topic by Ayubu Azizi on January 13, 2010
share your reaction | add to topics | report
save

GlaxoSmithKline to Provide Cheap Drugs to Developing Worldmore

GlaxoSmithKline, the world's second biggest pharmaceutical company, is to provide cheap drugs to millions of people in...

Telegraph. Added to topic by Kerry Capell on February 16, 2009
share your reaction | add to topics | report
save

Vaccines – the new money maker for Pharmamore

Long being regarded as an unattractive market, vaccines have re-emerged as successful growth driver for Big Pharma.

futurebiopharma.blogspot.com. Added to topic by Jennifer Pereira on April 24, 2009
share your reaction | add to topics | report
save

Prospects of non-clinical development of monoclonal antibodiesmore

One of many controversially discussed subjects is the need of studies in animals during the development of a biosimilar...

pharmatching.com. Added to topic by Henriette Frädrich on February 21, 2011
share your reaction | add to topics | report
save

EMA launches clinical trial registrymore

The European Medicines Agency has launched an online registry which, for the first time, gives the public access to...

pharmatching.com. Added to topic by Henriette Frädrich on March 24, 2011
share your reaction | add to topics | report
save

AstraZeneca to nearly double the size of its share repurchases in 2011more

AstraZeneca Plc plans to nearly double the size of its share repurchases in 2011 even though projected revenues remain...

pharmatching.com. Added to topic by Henriette Frädrich on January 28, 2011
share your reaction | add to topics | report
save

Do It for the Herdmore

Vaccines are often considered to be the greatest public health achievement of the 20th century. They are credited with...

thebeginner.eu. Added to topic by Ani Atanasova on May 23, 2011
share your reaction | 1 reaction | add to topics | report
save

TiGenix to merge with Spanish stem-cell companymore

TiGenix NV of Belgium and Cellerix SA of Spain have agreed to merge creating what is expected to be the largest cell...

pharmatching.com. Added to topic by Henriette Frädrich on February 25, 2011
share your reaction | add to topics | report
save

The top 10 health stories of 2009 (according to Harvard)more

Swine flu, health reform and restrictions on industry gifts to doctors are among the top 10 health stories identified...

srcomblog.wordpress.com. Added to topic by Ayubu Azizi on December 22, 2009
share your reaction | add to topics | report
save

Wall Street's 2009 Forecast and Analysis of Outsourcing Trendsmore

David: Forecast for industry growth, there is a dramatic growth in cancellations of gross bookings in the 2008.

partnershipswithcros.blogspot.com. Added to topic by Jennifer Pereira on May 4, 2009
share your reaction | add to topics | report
save

Orphan drug designation in the EU and the USmore

Pharmaceutical companies play the major role in the provision of medicines in the health systems of the EU and the US...

pharmatching.com. Added to topic by Henriette Frädrich on March 28, 2011
share your reaction | add to topics | report
save

FDA Approves Merck's SYLATRON™ (peginterferon alfa-2b) for Injection, ...more

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck (NYSE:MRK - News) (known as MSD outside the United States and Canada)...

finance.yahoo.com. Added to topic by Arlene Sanchez on April 12, 2011
share your reaction | add to topics | report
save

ECJ strikes down proposed patent courtmore

The European Court of Justice (ECJ) has struck down a proposal from member states of the European Union to create a...

pharmatching.com. Added to topic by Henriette Frädrich on March 9, 2011
share your reaction | add to topics | report
save

Handicapping Continues In The Drug Sectormore

Ever since last week’s announcement that Pfizer (PFE) will acquire Wyeth (WYE) unconfirmed rumors have swirled that...

blogs.barrons.com. Added to topic by Cathy Arnst on February 3, 2009
share your reaction | add to topics | report
save

Amgen Drug's Prostate Study Results May Boost Sales by $2 Billion a Ye...more

Amgen Inc. ’s denosumab delayed the spread of prostate cancer to men’s bones in a study that may help boost sales by $2...

bloomberg.com. Added to topic by I.J. Ikavalko on December 18, 2010
share your reaction | add to topics | report
save

The Maya of Pandemics « Quick Take – As It Happensmore

NDM-1 story is sounding too much like ‘AIDS-started-in-Africa’ kind of story. While Honk-Kong and China were being...

quicktake.wordpress.com. Added to topic by Anuraag Sanghi on June 2, 2011
share your reaction | 2 reactions | add to topics | report
save

Branded drug prices soar as generic pressure risesmore

S. prices for brand-name drugs are rising faster than ever as patents expire on top-selling medicines and the...

Reuters India. Published on March 23, 2011
share your reaction | add to topics | report
save

Pharma KnowHow: Press comment on the early retirement of Pfizer’s CEOmore

*Published with kind permission of* "MedNous":http://www.mednous.com The unexpected early...

pharmatching.com. Added to topic by Henriette Frädrich on December 13, 2010
share your reaction | add to topics | report
save

Your Strongest Ally: Amphastar Pharmaceuticals files new appeal in FDA...more

Amphastar Pharmaceuticals files new appeal in FDA conflict-of-interest case Los Angeles Times - Andrew Zajac The drug...

myharvardnews.com. Added to topic by Dawn Gutman on January 21, 2010
share your reaction | add to topics | report
save

UnitedHealth Says Diabetes Will Cost $3.4 Trillion Over Decade - Bloom...more

The disease will cost the nation almost $3.4 trillion in the 10 years through 2020, with more than 60 percent paid for...

bloomberg.com. Added to topic by I.J. Ikavalko on November 24, 2010
share your reaction | 1 reaction | add to topics | report
save

The Pharma Files: AstraZeneca Finally Gives Up On Iressa Approvalmore

In 2005, AstraZeneca ran into a problem with its Iressa cancer drug, which had been approved two years earlier to treat...

thepharmafiles.com. Added to topic by Arlene Sanchez on February 10, 2011
share your reaction | add to topics | report
save

Merck Drug Improves Cholesterol Without Safety Risk of Pfizer Pill - B...more

An experimental drug from Merck & Co. raised levels of good cholesterol, slashed bad cholesterol and may have...

bloomberg.com. Added to topic by I.J. Ikavalko on November 22, 2010
share your reaction | add to topics | report
save

What’s the matter with monoclonal antibodies?more

Looking at the CHMP monthly reports in 2010 one could get the impression that the monoclonal boom has passed its peak.

pharmatching.com. Added to topic by Henriette Frädrich on January 24, 2011
share your reaction | add to topics | report
save

Do cancer stem cells really exist?more

Despite the many achievements of modern cancer therapies, one uncertainty continues to haunt the industry.

pharmatching.com. Added to topic by Henriette Frädrich on February 2, 2011
share your reaction | add to topics | report
save

FDA Limits High-Dose Zocor, Backing Earlier Concerns For Second-Most P...more

Facebook is a social utility that connects people with friends and others who work, study and live around them.

facebook.com. Added to topic by Arlene Sanchez on June 9, 2011
share your reaction | add to topics | report
save
Topic Feed: Most active content in Pharmaceutical Industry

Top Sources: Pharmaceutical Industry

  • BusinessWeek
  • bloomberg.com
  • pharmachemicalscoatings.blogspot.com
  • Reuters
  • srcomblog.wordpress.com
  • New York Times
  • Industry Week
  • pharmatching.com
  • myharvardnews.com
  • online.wsj.com

Most Active Users in this Topic

Dawn Gutman Profile
save
Arlene Weintraub Profile
save
Jennifer Pereira Profile
save
Neil Gross Profile
save
I.J. Ikavalko Profile
save
see all contributors in Pharmaceutical Industry

Featured White Papers

Tweets on this Topic

Post a Job

Jobs in this Topic

Pharmaceutical Sales Representative Caswood Group | Los Angeles, CA
Posted: May 25
Advisory Health Industries R&D Director PwC | Jersey City, NJ
Posted: May 27
Health Industries IT Pharma Managed Markets Manager PwC | Philadelphia, PA
Posted: Mar 9
Senior Manager, Managed Markets (Pharmaceutical) Novo Nordisk | Princeton, NJ
Posted: May 28
Editor - Online B2B Pharmaceutical Publications Online B2B Pharmaceutical Publications | New York, NY
Posted: May 7

Report comment contains invalid characters. ()
cancel
Search Cancel